Pneumonia Guide vs CV Risk Estimation

Pneumonia Guide distills and organizes the guidance found in the 2019, 2016, 2007, and 2005 American Thoracic Society & Infectious Disease Society of America guidelines on management of Community Acquired Pneumonia and Hospital Acquired Pneumonia and the 2011 IDSA Pediatric Community Acquired Pneumonia guideline. The app addresses such common questions as: * what criteria are useful in deciding which community acquired pneumonia patients should be hospitalized? * what are those big-gun antibiotics for adult hospital acquired pneumonia, and what are the alternatives for those with medication allergies? * how long should antibiotics be continued? * exactly which pneumonia cases are considered to be hospital acquired? * which community acquired pneumonia patients require coverage for resistant organisms? * which hospitalized patients should be in the ICU? * which antibiotics are appropriate initial therapy for children with pneumonia? This app is written and intended for practicing clinicians like family physicians, internists, pediatricians, ER docs, and hospitalists; for resident physician trainees; and for medical students. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.

This app is for CLINICIANS, not the lay public. The CV Risk app presents clinicians with three valuable 10-year cardiovascular event risk calculators to serve clinicians and learners in primary prevention of cardiovascular disease. It is for clinicians only, not the lay public. The calculators are Framingham 2008, ASCVD 2013, and the revised pooled cohort equations ASCVD of 2018. The app addresses such common questions as: • What is the ASCVD 10-year CV risk for a 57 year old male hypertensive smoker with a given set of lipid and blood pressure numbers? • What’s the magnitude of impact of a patient on their own improving their cholesterol by 11, 27, or 41 points? • For a poorly controlled hypertensive smoker with a 10-year risk of 31.3%, how impactful would improved blood pressure control or smoking cessation be? • How impactful is a cholesterol of 220 on a given patient's risk at 35 vs. 55 vs. 75 years old? • I hear that ASCVD 2013 overestimates risk, particularly for black adults? True? What about the revised pooled cohort equations of 2018? The app explicitly does not include treatment thresholds, LDL targets, estimates of impact of therapy, coronary calcium scoring, etc. I wanted the cleanest simplest tool possible for evaluating and discussing cardiovascular risk with all the other more subjective, controversial stuff out of the way. This app is written and intended for practicing clinicians like internists and family physicians; for resident physician trainees; for medical students; and of course for other clinician colleagues like NP's and PA's. Cardiologists could use this app, but you folks are focused on secondary prevention, which is an entirely different ballgame. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.